Asclepius Introduction  

Asclepius Meditec pioneers molecular "Hydrogen-Oxygen Diet Medicine" in the world,  has been deeply engaged in scientific research for 13 years, focusing on the research and clinical application of molecular  Hydrogen-Oxygen Diet Medicine.

Asclepius Meditec has proved the clinical application value of Hydrogen-Oxygen Diet Medicine, covering respiratory and lung diseases, respiratory and sleep disorders, neurodegenerative diseases, cancer adjuvant therapy and rehabilitation, diabetes and stroke.

In 2020, it was granted the first  CFDA certificate of three types of medical devices (national 20203080066). In 2023, it was granted the second CFDA certificate of class-III Medical Devices Certification (National Equipment Registration 20233081929). Also was authorized with Chinese National Invovation Prize.